Eurofins Scientific, the French biotech company, is going ahead with its secondary listing on the Neuer Markt, despite a slump in stocks on Frankfurt's high-growth market and amid worries of a possible meltdown.

WestLB Panmure, HSBC Trinkaus and Credit Lyonnais will today open the books on Eurofins Scientific, which has been listed for almost exactly three years on France's Nouveau Marché. Its listing on the Neuer Markt is still set for October 26.